Bioventus Inc.BVSNASDAQ
Loading
Net Margin Over TimeExpanding
Percentile Rank83
5Y CAGR-4.8%
Studio
Year-over-Year Change

Net income as a percentage of revenue

5Y CAGR
-4.8%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM4.00%+168.4%
2024-5.85%+80.8%
2023-30.49%+1.6%
2022-30.99%-789.2%
20214.50%-12.0%
20205.11%+153.7%
20192.01%+152.7%
2018-3.82%-581.5%
2017-0.56%+91.4%
2016-6.54%-